Overview

Pharmacological Effects of PascoflairĀ® on Brain Activity in Patients Suffering From Test Anxiety

Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
Proof of effectiveness of Pascoflair using qantitative measurement of electric brain activity during examination stress in 40 subjects suffering from test anxiety. A double-blind, randomized, placebo-controlled, 2-armed, Phase IV study in parallel design.
Phase:
Phase 4
Details
Lead Sponsor:
Pascoe Pharmazeutische Praeparate GmbH
Collaborator:
NeuroCode AG